Clinical trial
National Active Surveillance Network and Pharmacogenomics of Adverse Drug…
NCT00414115 · University of British Columbia, Other · Recruiting
Key facts
| NCT number | NCT00414115 |
|---|---|
| Title | National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children |
| Official title | Canadian Pharmacogenomics Network for Drug Safety |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Genome Canada Genome British Columbia Industry Child and Family Research Institute Western University, Canada Provincial Health Services Authority British Columbia Health Canada Canada Gene Cure Eli… |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Adverse Drug Reaction (ADR) |
| Enrollment | 7,000 |
| Start date | Aug 1, 2005 |
| Primary completion | Mar 1, 2029 |
| Completion | Mar 1, 2029 |
| First posted | Dec 21, 2006 |
| Last update posted | Mar 27, 2025 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: